All In Biotech

Drug Trial Radar · NCT00196755

Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis

An Open Label, Randomized, Parallel Design Study to Investigate the Efficacy and Safety of Sevelamer Hydrochloride (Renagel®) Compared With Calcium Acetate in Peritoneal Dialysis Patients

Last checked: Nov 20, 2026Latest source record: Mar 18, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 138 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

138

Actual

Start

Dec 2004

Primary completion

Mar 2006

Study completion Apr 2006

Sponsor

Lead sponsor
Genzyme, a Sanofi CompanySanofi (SNY)
Sponsor type
Industry
First posted
Sep 20, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate that sevelamer hydrochloride is non-inferior to calcium acetate for the treatment of hyperphosphataemia in patients receiving peritoneal dialysis.

Conditions

  • Peritoneal Dialysis
  • Chronic Kidney Disease

Interventions

  • Sevelamer Hydrochloride (Renagel®)Drug

    Sevelamer hydrochloride three times per day with each meal

  • Calcium acetate (PhosLo® )Drug

    Calcium acetate three times per day with each meal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Compare the effects of sevelamer dosed three times per day (TID) and calcium acetate dosed TID on serum phosphorus.Time frame: 12 weeks

Locations

17 sites in 7 countries. Site status is shown where the registry gives one.

  • UZ Gasthuisberg

    Leuven, Belgium

  • Aarhus University Hospital

    Århus N, Denmark

  • Fredericia Sygehus

    Fredericia, Denmark

  • Copenhagen University Hospital

    Herlev, Denmark

  • CHRU Clémenceau

    Caen, France

  • Ospedale civico e benfratelli

    Palermo, Italy

  • Ospedale San Bortolo

    Vicenza, Italy

  • AMC

    Amsterdam, Netherlands

  • Fundacion Jimenez Diaz

    Madrid, Spain

  • Hospital Universitario La Paz

    Madrid, Spain

  • University Hospital ,Queen Elizabeth Hospital

    Birmingham, United Kingdom

  • High Wycombe Hospital

    Buckinghamshire, United Kingdom

  • University of Wales College of Medicine

    Cardiff, United Kingdom

  • Glasgow Western Infirmary

    Glasgow, United Kingdom

  • Royal Hospital The Royal London

    London, United Kingdom

  • Milton Keynes General Hospital

    Milton Keynes, United Kingdom

  • The Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust

    Oxford, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.